Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.31.1 (
micrococcal nuclease
)
2,818
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have previously constructed a yeast strain (UKY403) whose sole histone H4 gene is under control of the GAL1 promoter. This yeast arrests in G2 upon glucose treatment as a result of histone H4 depletion. The yeast PHO5 gene contains phase nucleosomes covering promoter (UAS) sequences in the PHO5 repressed state and it has been suggested that nucleosomes prevent the binding of positively acting factors to these UAS sequences. Using UKY403 we examined the length of polynucleosomes and nucleosome phasing in the PHO5 upstream region by the use of
micrococcal nuclease
and indirect end-labeling. It was found that glucose arrest led to a severe disruption in PHO5 chromatin structure and that most nucleosomes had their position altered or were lost from the PHO5 promoter region. Cell undergoing nucleosome depletion synthesized large quantities of accurate PHO5 transcripts even under repressive, high inorganic phosphate conditions.
Histone H4
depletion did not appear to affect the repression or activation of another inducible yeast gene, CUP1. Arrest with landmarks in early G1 (in the cell division cycle mutant cdc28) or in various stages of G2 (in cdc15, cdc17 and cdc20) does not activate PHO5; nor does arrest due to chromosome topology changes (in top2 or the top1top2 topoisomerase mutants). cdc14, which has its arrest landmark at a similar point in the cell cycle as cdc15, does derepress PHO5. However, since it also leads to derepression of CUP1 it is probably functioning through an independent mechanism. Therefore, our data suggest that nucleosomes regulate PHO5 transcription.
...
PMID:Depletion of histone H4 and nucleosomes activates the PHO5 gene in Saccharomyces cerevisiae. 304 34
In previous work [Hay, C. W., & Candido, E. P. M. (1983) J. Biol. Chem. 258, 3726-3734], we have shown that the histone deacetylase from HeLa cell nuclei is associated with a high molecular weight, nuclease-resistant complex. This complex was found to contain a variety of non-histone proteins, and indirect evidence for the importance of protein-protein interactions in the maintenance of its structure was obtained. In the present report, we examine the effects of beta-mercaptoethanol and neocuproine on the deacetylase complex and present data on the level of histone acetylation and the presence of satellite DNA sequences in this material. HeLa cell histone deacetylase complex partially dissociates in 10 mM beta-mercaptoethanol, resulting in a loss of non-histone proteins. The presence of 10 mM beta-mercaptoethanol during the
micrococcal nuclease
digestion of HeLa cell nuclei results in a greatly reduced yield of histone deacetylase complex, with a correspondingly large increase in the production of small oligonucleosomes and mononucleosomes. Histone deacetylase activity on endogenous labeled histone within the complex is strongly inhibited by either 1 or 10 mM beta-mercaptoethanol or 3 mM neocuproine. This loss of histone deacetylase activity does not seem to be due to an inactivation of the enzyme but appears to be a consequence of the disruption of the structure of the deacetylase complex itself.
Histone H4
in the deacetylase complex prepared from HeLa cell nuclei by
micrococcal nuclease
digestion was more highly acetylated than H4 in bulk nucleosomes. Restriction enzyme analysis of the DNA associated with the histone deacetylase complex revealed neither an enrichment nor a depletion of major satellite sequences in this material.
...
PMID:Histone deacetylase from HeLa cells: properties of the high molecular weight complex. 631 8